Israel Englander’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$691K Sell
202,018
-272,770
-57% -$848K ﹤0.01% 4564
2026
Q1
$1.08M Sell
474,788
-2,222,093
-82% -$5.12M ﹤0.01% 4330
2025
Q4
$7.55M Sell
2,696,881
-564,373
-17% -$2.02M ﹤0.01% 2565
2025
Q3
$15.7M Buy
3,261,254
+2,143,267
+192% +$13.6M 0.01% 1937
2025
Q2
$10.2M Buy
1,117,987
+1,056,505
+1,718% +$7.79M ﹤0.01% 2236
2025
Q1
$555K Buy
61,482
+1,960
+3% +$20.7K ﹤0.01% 4743
2024
Q4
$778K Sell
59,522
-167,229
-74% -$2.23M ﹤0.01% 4400
2024
Q3
$3.56M Buy
226,751
+92,789
+69% +$1.41M ﹤0.01% 3150
2024
Q2
$1.81M Buy
133,962
+80,663
+151% +$1.65M ﹤0.01% 3613
2024
Q1
$1.48M Sell
53,299
-314,624
-86% -$6.99M ﹤0.01% 3987
2023
Q4
$7.09M Buy
367,923
+261,223
+245% +$4.73M ﹤0.01% 2492
2023
Q3
$1.72M Sell
106,700
-100,204
-48% -$1.78M ﹤0.01% 3700
2023
Q2
$3.94M Sell
206,904
-9,393
-4% -$168K ﹤0.01% 2882
2023
Q1
$3.15M Sell
216,297
-180,190
-45% -$3.23M ﹤0.01% 3013
2022
Q4
$7.74M Buy
396,487
+376,297
+1,864% +$7.34M ﹤0.01% 2397
2022
Q3
$487K Sell
20,190
-5,458
-21% -$168K ﹤0.01% 5003
2022
Q2
$807K Sell
25,648
-374,755
-94% -$13.6M ﹤0.01% 4567
2022
Q1
$17.6M Sell
400,403
-359,715
-47% -$15.4M 0.01% 1519
2021
Q4
$33.1M Buy
760,118
+459,218
+153% +$18M 0.02% 1023
2021
Q3
$9.41M Buy
300,900
+202,365
+205% +$7.96M 0.01% 2135
2021
Q2
$4.17M Sell
98,535
-15,506
-14% -$603K ﹤0.01% 2997
2021
Q1
$4.29M Sell
114,041
-349,173
-75% -$10.9M ﹤0.01% 2750
2020
Q4
$12.5M Sell
463,214
-297,779
-39% -$7.66M 0.01% 1501
2020
Q3
$19.1K Buy
+760,993
New +$11.1M 0.02% 820
2020
Q2
Sell
-69,925
Closed -$640K 4478
2020
Q1
$640K Buy
+69,925
New +$422K ﹤0.01% 2736
2019
Q4
Sell
-16,076
Closed -$93K 4517
2019
Q3
$93K Sell
16,076
-135,407
-89% -$607K ﹤0.01% 3982
2019
Q2
$485K Sell
151,483
-450,908
-75% -$1.54M ﹤0.01% 3260
2019
Q1
$2.47M Buy
602,391
+535,429
+800% +$3.39M ﹤0.01% 2271
2018
Q4
$424K Buy
66,962
+10,433
+18% +$108K ﹤0.01% 3055
2018
Q3
$934K Sell
56,529
-276,862
-83% -$4.71M ﹤0.01% 2910
2018
Q2
$5.57M Sell
333,391
-45,010
-12% -$729K 0.01% 1746
2018
Q1
$5.88M Buy
+378,401
New +$6.75M 0.01% 1703
2017
Q4
Sell
-338,209
Closed -$7.5M 3995
2017
Q3
$9.88M Buy
338,209
+245,882
+266% +$7.26M 0.02% 1253
2017
Q2
$2.97M Buy
92,327
+9,640
+12% +$316K 0.01% 1830
2017
Q1
$2.86M Buy
+82,687
New +$2.95M 0.01% 1791
2016
Q4
Sell
-769,287
Closed -$26.7M 3607
2016
Q3
$26.7M Sell
769,287
-3,067
-0.4% -$107K 0.04% 459
2016
Q2
$28.9M Buy
772,354
+399,963
+107% +$15M 0.07% 377
2016
Q1
$15.1M Buy
372,391
+228,530
+159% +$8.51M 0.04% 606
2015
Q4
$5.18M Buy
+143,861
New +$5.2M 0.01% 1338
2015
Q2
Sell
-39,649
Closed -$1.34M 3685
2015
Q1
$1.34M Sell
39,649
-105,690
-73% -$3.68M ﹤0.01% 2184
2014
Q4
$5.1M Buy
145,339
+81,618
+128% +$2.75M 0.01% 1380
2014
Q3
$2.09M Sell
63,721
-52,722
-45% -$1.79M 0.01% 1839
2014
Q2
$3.96M Buy
116,443
+56,719
+95% +$1.94M 0.01% 1358
2014
Q1
$2.09M Buy
59,724
+15,400
+35% +$543K 0.01% 1745
2013
Q4
$1.62M Sell
44,324
-11,897
-21% -$437K 0.01% 1962
2013
Q3
$1.95M Buy
56,221
+15,300
+37% +$535K 0.01% 1704
2013
Q2
$1.38M Buy
+40,921
New +$1.36M ﹤0.01% 1800

Other funds holding ACH

Israel Englander's ACH Position: Q2 2026 in Review

Israel Englander reduced its Accendra Health (ACH) stake by 57% in Q2 2026, selling an estimated $848K and leaving 202,018 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #4564.

Israel Englander first reported a position in ACH in Q2 2013 and has held it in 47 quarters since. The position peaked at $33.1M in Q4 2021. 138 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Israel Englander held 202,018 shares of Accendra Health worth $691K as of Q2 2026.
  • Israel Englander sold 272,770 Accendra Health shares in Q2 2026, an estimated $848K.
  • Accendra Health made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4564 holding.
  • Israel Englander first reported a position in Accendra Health in Q2 2013 and has held it in 47 quarters since.
  • Israel Englander's Accendra Health position peaked at $33.1M in Q4 2021.
  • 138 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.